Upload Avatar (500 x 500)
Xiaomeng Dai
Medical School
Zhejiang University
Zhejiang
Language: Chinese, English
Tumor
Macrophages
Translational Research
Drug Delivery
Immunotherapy
Single Cell
Immune Activation
Cancer
Therapeutic Target
Multiomics
Areas of Focus
- Targeting Tumor-Associated Macrophages: Basic and Translational Research
- Drug Delivery Systems and Immunotherapy
Academic Background & Achievements
- Master's Supervisor at Zhejiang University
- Distinguished Researcher at the First Affiliated Hospital of Zhejiang University
- Currently leading one National Natural Science Foundation Youth Project and one Zhejiang Provincial Natural Science Foundation Youth Project
- Editorial board member of Exploration Youth
- Reviewer for Journal for ImmunoTherapy of Cancer, Research, Cellular Signalling
- Published SCI articles with total citations > 1000, H-index 18
Publications
- A multiomics analysis-assisted deep learning model identifies a macrophage-oriented module as a potential therapeutic target in colorectal cancer, Bao XW+, Li Q+, Chen D+, Dai XM+, et al., 2024
- Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment, Jin YZ+, Huang YY+, Ren H+, …Zhao P* & Dai XM*, 2024
- Induction of Tumor Ferroptosis-Dependent Immunity via an Injectable Attractive Pickering Emulsion Gel, Dai XM+*, J Zhang+, XW Bao+, et al., 2023
- An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis, Bao XW+, Wang DY+, Dai XM+, et al., 2023
- Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma, Dai XM+, Guo YX+, Hu Y, et al., 2021
- Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules, Dai XM+, Ruan J+; Guo YX+, et al., 2021
- Targeting CAMKII to reprogram tumor- associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel, Dai XM+, Meng JS+, Deng SK+, et al., 2020
- USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer, Dai XM+, Lu LS+, Deng SK, et al., 2020
- Association of PD-L1 and HIF-1 alpha Coexpression with Poor Prognosis in Hepatocellular Carcinoma, Dai XM+, Pi GL+, Yang SL*, et al., 2018
- Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma, Dai XM+, Xue J+, Hu JL, et al., 2017
